Coronavirus anti drug

Coronavirus anti drug

It may take some more weeks for anti-viral drug remdesivir to available to Covid-19 patients in India as pharmaceutical companies, seeking to manufacture them domestically, are still performing on furnishing safety and quality data, albeit the approval process for its introduction is being fast-tracked.

The Union Health Ministry on Saturday, in its revised 'Clinical Management Protocol for Covid-19', recommended the utilization of remdesivir under emergency use authorization on patients with moderate disease -- that's those on oxygen support. it's not recommended for those with severe renal impairment and in children but 12 years, pregnant and lactating women